Amanda Balbi

Study: Celecoxib vs Ibuprofen vs Naproxen for Treating RA and OA

11/18/2016

Celecoxib, a selective Cox-2 nonsteroidal anti-inflammatory drug (NSAID), is non-inferior to prescription doses of ibuprofen and naproxen for treating patients with osteoarthritis (OA) and rheumatoid arthritis (RA), according to a...

Celecoxib, a selective Cox-2...

11/18/2016

Rheumatology & Arthritis

News

Sofosbuvir Treatments Show High Rates of Adherence and Virological Response

09/21/2016

Amanda Balbi ;

A recent study aimed to determine the impact of treatment adherence to sofosbuvir-based regimens on virological outcomes in patients with hepatitis C virus.

A recent study aimed to...

09/21/2016

Gastroenterology

RHEUMATOLOGY

George Karpouzas, MD, on Predictors of RA Treatment Adherence

04/17/2016

Amanda Balbi ;

He talks about his study that evaluated the unique and interactive roles of patient beliefs about the necessity of rheumatoid arthritis medications and concerns about them in predicting adherence to prescribed treatments.

He talks about his study...

04/17/2016

Rheumatology & Arthritis